URB754
4539781
215553605
2008-05-28T18:38:42Z
DOI bot
6652755
Citation maintenance. You can [[WP:DOI|use this bot]] yourself! Please [[User:DOI_bot/bugs|report any bugs]].
{{chembox new
| Name = URB754
| ImageFile = URB754.svg
| ImageSize = 250
| IUPACName =
| SystematicName =
| OtherNames =
| Section1 = {{Chembox Identifiers
| Abbreviations =
| CASNo = 86672-58-4
| EINECS =
| EINECSCASNO =
| PubChem =
| SMILES =
| InChI =
| RTECS =
| MeSHName =
| ChEBI =
| KEGG =
| ATCCode_prefix =
| ATCCode_suffix =
| ATC_Supplemental =}}
| Section2 = {{Chembox Properties
| Formula =
| MolarMass =
| Appearance =
| Density =
| MeltingPt =
| Melting_notes =
| BoilingPt =
| Boiling_notes =
| Solubility =
| SolubleOther =
| Solvent =
| LogP =
| VaporPressure =
| HenryConstant =
| AtmosphericOHRateConstant =
| pKa =
| pKb = }}
| Section3 = {{Chembox Structure
| CrystalStruct =
| Coordination =
| MolShape = }}
| Section4 = {{Chembox Thermochemistry
| DeltaHf =
| DeltaHc =
| Entropy =
| HeatCapacity = }}
| Section5 = {{Chembox Pharmacology
| AdminRoutes =
| Bioavail =
| Metabolism =
| HalfLife =
| ProteinBound =
| Excretion =
| Legal_status =
| Legal_US =
| Legal_UK =
| Legal_AU =
| Legal_CA =
| PregCat =
| PregCat_AU =
| PregCat_US = }}
| Section6 = {{Chembox Explosive
| ShockSens =
| FrictionSens =
| ExplosiveV =
| REFactor = }}
| Section7 = {{Chembox Hazards
| ExternalMSDS =
| EUClass =
| EUIndex =
| MainHazards =
| NFPA-H =
| NFPA-F =
| NFPA-R =
| NFPA-O =
| RPhrases =
| SPhrases =
| RSPhrases =
| FlashPt =
| Autoignition =
| ExploLimits =
| LD50 =
| PEL = }}
| Section8 = {{Chembox Related
| OtherAnions =
| OtherCations =
| OtherFunctn =
| Function =
| OtherCpds = }}
}}
'''URB754''' was originally reported to be a potent, noncompetitive inhibitor of [[monoacylglycerol lipase]].<ref name="pmid16116451">{{cite journal |author=Makara JK, Mor M, Fegley D, Szabó SI, Kathuria S, Astarita G, Duranti A, Tontini A, Tarzia G, Rivara S, Freund TF, Piomelli D |title=Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus |journal=Nat. Neurosci. |volume=8 |issue=9 |pages=1139–41 |year=2005 |pmid=16116451 |doi=10.1038/nn1521}}</ref> However, recent studies have shown that URB754 failed to inhibit recombinant MGL, and brain [[FAAH]] activity was also resistant to URB754.<ref>{{cite journal |author=Saario SM, Palomäki V, Lehtonen M, Nevalainen T, Järvinen T, Laitinen JT |title=URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain |journal=Chem. Biol. |volume=13 |issue=8 |pages=811–4 |year=2006 |pmid=16931330 |doi=10.1016/j.chembiol.2006.07.008}}</ref> Some controversy in the field remains regarding the use of this compound.
<!-- Whoever wants to read the following, can go to the 2-AG article. Otherwise, rewrite it better
[[2-Arachidonoylglycerol]] (2-AG) is an endogenous agonist of the central cannabinoid receptor (CB1) receptor.[1,2] It is present at relatively high levels in the central nervous system and is the most abundant molecular species of monoacylglycerol found in rat brain.[1,3] [[Monoacylglycerol lipase]] (MGL) hydrolyzes 2-AG to [[arachidonic acid]] and glycerol, thereby terminating its biological actions.[4]
-->
==References==
<references/>
<!--
# Stella, N., Schweitzer, P., Piomelli, D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778 (1997).
# Sugiura, T., Kodaka, T., Nakane, S., et al. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J Biol Chem 274, 2794-2801 (1999).
# Kondo, S., Kondo, H., Nakane, S., et al. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: Identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+-dependent and -independent mechanisms. FEBS Lett 429, 152-156 (1998).
# Dinh, T.P., Carpenter, D., Leslie, F.M., et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99(16), 10819-10824 (2002).
# Makara, J.K., Mor, M., Fegley, D., et al. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nature Neuroscience 8(9), 1139-1141 (2005).
# Hohmann, A.G., Suplita, R.L., Bolton, N.M., et al. An endocannabinoid mechanism for stress-induced analgesia. Nature 435, 1108-1112 (2005).
-->
{{Cannabinoids}}
{{pharma-stub}}